Peetz Christopher sold MIRM
September 1, 2026 · Form 4 insider transaction
Peetz Christopher sold 21,688 shares of Mirum Pharmaceuticals, Inc. at $98.91 per share, a transaction worth $2.15M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
21,688
Price
$98.91
Total value
$2.15M
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after194,440
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $98.91, and the range of prices were between $98.49 and $99.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.